Baxter International (BAX) Non-Current Assets (2009 - 2026)
Baxter International's (BAX) quarterly Non-Current Assets came in at $13.0 billion in Q1 2026, down 8.9% year-on-year from $14.3 billion in Q1 2025, and down 1.4% on a QoQ basis from $13.2 billion in Q4 2025.
Baxter International (BAX) Non-Current Assets (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Non-Current Assets data on file, last reported at $13.0 billion in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 8.9% year-over-year to $13.0 billion in Q1 2026; TTM through Mar 2026 was $54.6 billion, a 18.16% decrease from a year earlier, with the FY2025 full-year figure at $13.2 billion, down 22.13% from the prior year.
- Non-Current Assets for Q1 2026 stood at $13.0 billion, down from $13.2 billion in the prior quarter.
- Over the last five years, Non-Current Assets for BAX reached as high as $24.5 billion in Q1 2022 and fell as low as $13.0 billion in Q1 2026.
- Historically, Non-Current Assets has averaged $18.0 billion across 5 years, with a median of $18.4 billion in 2024.
- Across the five-year window, Non-Current Assets soared 111.4% in 2022 and retreated 22.4% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $20.3 billion in 2022, then dropped by 7.89% to $18.7 billion in 2023, then decreased by 9.35% to $16.9 billion in 2024, then slipped by 22.13% to $13.2 billion in 2025, then dropped by 1.4% to $13.0 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $13.0 billion in Q1 2026, $13.2 billion in Q4 2025, and $14.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 25.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 42.82 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 27.83 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 4.72 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 10.18 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 10.51 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 3.66 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 13.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Bn |
| Dec 31, 2025 | 13.18 Bn |
| Sep 30, 2025 | 14.13 Bn |
| Jun 30, 2025 | 14.30 Bn |
| Mar 31, 2025 | 14.27 Bn |
| Dec 31, 2024 | 16.93 Bn |
| Sep 30, 2024 | 17.81 Bn |
| Jun 30, 2024 | 17.72 Bn |
| Mar 31, 2024 | 18.39 Bn |
| Dec 31, 2023 | 18.68 Bn |
| Sep 30, 2023 | 18.62 Bn |
| Jun 30, 2023 | 19.68 Bn |
| Mar 31, 2023 | 20.19 Bn |
| Dec 31, 2022 | 20.28 Bn |
| Sep 30, 2022 | 20.16 Bn |
| Jun 30, 2022 | 23.95 Bn |
| Mar 31, 2022 | 24.54 Bn |
| Dec 31, 2021 | 24.65 Bn |
| Sep 30, 2021 | 11.64 Bn |
| Jun 30, 2021 | 11.68 Bn |